Outcomes of VDPACE with Immunomodulator Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Abdallah, Al-Ola [1 ]
Shune, Leyla [1 ]
Hochard, Erica [1 ]
Dunavin, Neil [1 ]
Mahmoudjafar, Zahra [1 ]
Ganguly, Siddhartha [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Multiple Myeloma; Extramedullary disease; Plasmacytoma;
D O I：
10.1016/j.clml.2018.07.145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-215
引用
收藏
页码：S247 / S247
页数：1
相关论文
共 50 条
  • [1] Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease
    Abdallah, Al-Ola
    Mohyuddin, Ghulam Rehman
    Ahmed, Nausheen
    Mohan, Meera
    Cui, Wei
    Shune, Leyla
    Mahmoudjafari, Zahra
    McGuirk, Joseph
    Ganguly, Siddhartha
    Atrash, Shebli
    EJHAEM, 2021, 2 (04): : 757 - 764
  • [2] Outcomes of Vdpace with Immunomodulator Treatment in Initial and Relapsed/Refractory Multiple Myeloma in a Single Center
    Abdallah, Al-Ola
    McGuirk, Joseph P.
    Shune, Leyla
    Hochard, Erica
    Dunavin, Neil
    Mahmoudjafari, Zahra
    Ganguly, Siddhartha
    BLOOD, 2017, 130
  • [3] Outcomes of VDPACE with an Immunomodulatory Agent (IMiD) as a Salvage Therapy in Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD)
    Abdallah, Al-Ola
    Atrash, Shebli
    Mahmoudjafari, Zahra
    McGuirk, Joseph
    Ganguly, Siddhartha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S302 - S303
  • [4] Outcomes of Vdpace for Relapsed/Refractory Multiple Myeloma in the Era of Daratumumab Based Therapy
    Venkatesh, Priyanka
    Khasawneh, Ghena
    Hashmi, Hamza
    Alkharabsheh, Omar
    Paul, Barry
    Skikne, Barry S.
    Mahmoudjafari, Zahra
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Atrash, Shebli
    BLOOD, 2023, 142
  • [5] Vdpace As Salvage Therapy in Triple Class Relapse/Refractory Multiple Myeloma
    Venkatesh, Priyanka
    Shatnawi, Sara
    Shatnawi, Yara
    Shaikh, Hira
    Strouse, Christopher
    Atrash, Shebli
    Mushtaq, Muhammad Umair
    Ahmed, Nausheen
    Mahmoudjafari, Zahra
    Abdallah, Al-Ola
    Shune, Leyla
    BLOOD, 2023, 142
  • [6] Outcomes of VD-PACE With Immunomodulatory Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma
    Abdallah, Al-Ola
    Sigle, Monia
    Mohyuddin, Ghulam Rehman
    Coggins, Emily
    Remker, Cassie
    Shune, Leyla
    Mahmoudjafari, Zahra
    McGuirk, Joseph
    Ganguly, Siddhartha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E220 - E226
  • [7] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, M.
    Truger, M.
    Bittrich, M.
    Zhou, X.
    Noderer, J.
    Riedhammer, C.
    Xiao, X.
    Gawlas, S.
    Philipp, W.
    Eisele, F.
    Haferlach, C.
    Mersi, J.
    Waldschmidt, J.
    Einsele, H.
    Rasche, L.
    Kortuem, K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 58 - 58
  • [8] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, Maximilian J.
    Truger, Marietta
    Bittrich, Max
    Zhou, Xiang
    Noderer, Julia
    Riedhammer, Christine
    Xiao, Xianghui
    Gawlas, Sophia
    Weis, Philipp
    Eisele, Florian
    Haferlach, Claudia
    Mersi, Julia
    Waldschmidt, Johannes
    Einsele, Hermann
    Rasche, Leo
    Kortuem, K. Martin
    HAEMATOLOGICA, 2024, 109 (03) : 979 - 981
  • [9] Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
    Tosi, P
    Zamagni, E
    Cellini, C
    Ronconi, S
    Patriarca, F
    Ballerini, F
    Musto, P
    Di Raimondo, F
    Ledda, A
    Lauria, F
    Masini, L
    Gobbi, M
    Vacca, A
    Ria, R
    Cangini, D
    Tura, S
    Baccarani, M
    Cavo, M
    HAEMATOLOGICA, 2002, 87 (04) : 408 - 414
  • [10] Therapy of relapsed and relapsed refractory multiple myeloma
    Driessen, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 113 - 113
12345